56
PDGF-APP(WT) APP (line I5)
APP-WT driven by the human PDGF-β promoter; an APP transgene with the Indiana mutation was converted to wild-type by PCR primer modification. Transgene expresses human APP driven by the mouse prion protein promoter. Transgene human PSEN1 with the A246E mutation driven by the mouse thy1 promoter.
57
Prnp-APP
APP
58
PS1(A246E)
PSEN1
59
PS1 cKO
PS1 conditional KO mice with selective deletion of PSEN1 in excitatory neurons of the forebrain beginning about 1 month of PSEN1 age post-natally were generated by crossing a floxed PS1 mouse with a CamKII-Cre transgenic mouse.
60
PS1(M146L)
PSEN1
Transgene containing human PSEN1 with the M146L mutation driven by the rat PDGF-β promoter.
61
PS1(M146V)
PSEN1
Transgene containing human PSEN1 with the M146V mutation driven by the rat PDGF-β promoter.
62
PS1 P264L
An exon replacement strategy was used to generate mouse lines carrying a targeted mutation in their endogenous presenilin-1 gene. A proline-to-leucine substitution was targeted to codon 264 PSEN1 in exon 8 by homologous recombination in embryonic stem (ES) cells. Cre-lox system to remove the neomycin selection cassette from the targeted gene. Coinjection of two transgenes into C57/Bl/6 zygotes: Human APP, PSEN2 gene with the N141I mutation driven by the mouse prion PSEN2 protein promoter and human APP751 with the Swedish mutation driven by the Thy1.2 promoter.
63
PS2APP
Double transgenics created by crossing APPSwe mice
64
PS2APP (transgene containing the 751 isoform of human APP with the APP, (PS2(N141I) PSEN2 Swedish mutation driven by the Thy1.2 promoter) with PS2(N141I) mice (tansgene containing human PSEN2 with the x APPswe) N141I mutation driven by the mouse prion protein promoter). Human PSEN2 gene with the N141I mutation driven by the mouse prion protein promoter.
65
PS2(N141I)
PSEN2

Regimen Summary of Peptide Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD...
第二节 阿尔茨海默病(Alzheimer's disease,AD)阿尔茨海默病(Alzheimer's disease,AD) ,是发生于老年和老年前期、以 进行性认知功能障碍和行为损害为特征的中枢...
Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD Transgenic Mice Medicine ?...
阿尔茨海默病(Alzheimer’SDisease,AD)与动力相关蛋白1(dynamin—relatedprotein1,Drp1)_基础医学_医药卫生_专业资料。第3 0卷第 2期 201 3年 4月 生物学...
让我们向江教练致敬,并祝老年痴呆症患者早日康复! 治疗老年痴呆症的小偏方所谓的老年痴呆症,又称阿尔茨海默病(alzheimer's disease,ad)是发生在老年期及老年前期...
b.老年痴呆病 老年性痴呆病,分为阿尔茨海默病(Alzheimer’sdisease,AD)和血管性痴呆(VD) ,是一 种发病于老年期前后的原发性大脑退行性疾病。 近年来老年性痴呆...
老年痴呆症的护理 老年痴呆症又称阿尔茨海默病 (Alzheimer's disease,AD) 是发生在老年期及老年前期的一种 原发性退行性脑病, 指的是一种持续性高级神经功能...
In order to study AD pathology and develop AD ...Using Tg6799 as a mouse model for AD research ...(Alzheimer’s disease,AD)又称老年痴呆症,是一...
Alzheimer's disease 老年痴呆症Alzheimer's disease 老年痴呆症隐藏>> review article Pathways towards and away from Alzheimer’s disease Mark P. Mattson ...
老年痴呆症,又称阿尔茨海默病 (Alzheimer's disease,AD) 是发生在老年期 及老年前期的一种原发性退行性脑病,指 的是一种持续性高级神经功能活动障碍, 即在没...
热门文档